RecruitingPhase 3NCT07355218
Rare condition
Subacute cutaneous lupus erythematosus
4
studies recruiting now
as of 7 Sept 2026
21
studies registered in total
as of 7 Sept 2026
6
countries with a recruiting site
as of 7 Sept 2026
9 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07332481
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RecruitingPhase 2NCT07694336
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
RecruitingPhase 4NCT06875960
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Subacute cutaneous lupus erythematosus studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Subacute cutaneous lupus erythematosus study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Subacute cutaneous lupus erythematosus
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 22 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Hydroxychloroquine Sulfate (Hydroxychloroquine sulfate)
Phase 3Sirukumab
Phase 3Litifilimab
Phase 3Hydroxychloroquine
Phase 3Anifrolumab (Saphnelo)
Phase 2Niacinamide (Freederm)
Phase 2Dovramilast
Phase 2Alitretinoin (Panretin)
Phase 2Eclitasertib
+ 14 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).